We reviewed endoscopic hemostatic effects of the pure @entity1068 injection ( @entity8681 ) method for reducing emergency operations and deaths due to gastroduodenal @entity1066 . During 17 years beginning in June 1979 in Tohoku University Hospital, 331 @entity1 underwent endoscopic hemostasis by the @entity8681 method. Initial hemostasis was successfully obtained in all cases. Rebleeding occurred in about 4% of the @entity1 , and rehemostasis was obtained successfully in all of them. Complete hemostasis was obtained in 330 of 331 @entity1 (99. 7%) using the @entity8681 method; there were no deaths. Only one @entity1 required emergency operation after hemostasis because of repeated @entity548 complicated with a perforation and another because of an unidentifiable neogenetic @entity1066 located just above the @entity21151 . None required other endoscopic hemostasis or interventional radiology. Moreover, after introduction of "second-look" endoscopy, the rebleeding rate decreased to about 1% with @entity8681 hemostasis. Based on these excellent hemostatic effects of the @entity8681 method, we believe that a comparative study with other hemostatic methods is not needed.

Efficacy of endoscopic pure XXXX injection method for gastrointestinal @entity1066 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity548 :: ('MESH:D006470', 'Disease') :: ['neogenetic bleeding'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcer bleeding'] @entity8681 :: ('CHEBI:53231', 'Chemical') :: ['PEI'] @entity1068 :: ('MESH:D000431', 'Chemical') :: ['ethanol'] @entity21151 :: ('MESH:C536534', 'Disease') :: ['Vater papilla']
@entity1068 :: (MESH:D000431,Chemical) :: ['ethanol']
